CTI BioPharma Corp. (DE) Common Stock

CTIC

Capitalización de mercado USD 1199 M

Acerca de: CTI BioPharma Corp is a biopharmaceutical company focused on the acquisition, development, and commercialization of less toxic and more effective cancer therapies. Its therapeutic area is blood-related cancers. Its products under the pipeline include Pacritinib. Pacritinib is an investigational oral kinase inhibitor for the treatment of adult patients with myelofibrosis.

Empleados: 128